Scientific Publications by FDA Staff
DNA Cell Biol 2008 Apr;27(4):191-8
Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin.
Neznanov N, Kondratova A, Chumakov KM, Neznanova L, Kondratov R, Banerjee AK, Gudkov AV
Neznanov, N (reprint author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA US FDA, Ctr Biol Evaluat & Res, Rockville, MD USA Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA Cleveland Biolabs, Buffalo, NY USA
Flavonoid quercetin and its derivative, methylquercetin, inhibit the replication of poliovirus in several cell lines. Here, we show that replication of poliovirus is inhibited by quercetin and that the extent of this inhibition depends on the intracellular content of pirin, a quercetinase. HeLa cells contain higher content of pirin protein than normal kidney human epithelial (NKE) or 293 cells do. Poliovirus replication in HeLa cells is significantly more resistant to quercetin than its replication in NKE and 293 cells. Overexpression of pirin reduced antiviral inhibitory effect of quercetin, while siRNA-induced suppression of pirin level made poliovirus replication more sensitive to the flavonoid. The results suggest that quercetinase activity of pirin determines the resistance of poliovirus infection to quercetin.
|Category: Journal Article|
|PubMed ID: #18067462|
|Includes FDA Authors from Scientific Area(s): Biologics|
|Entry Created: 2011-10-04||Entry Last Modified: 2012-08-29|